153 related articles for article (PubMed ID: 22739529)
1. Drugs for treating Parkinson disease.
Belavic J
Nursing; 2012 Jul; 42(7):69. PubMed ID: 22739529
[No Abstract] [Full Text] [Related]
2. Parkinson disease treatment in hospitals and nursing facilities: avoiding pitfalls.
Ahlskog JE
Mayo Clin Proc; 2014 Jul; 89(7):997-1003. PubMed ID: 24996235
[TBL] [Abstract][Full Text] [Related]
3. Finasteride attenuates pathological gambling in patients with Parkinson disease.
Bortolato M; Cannas A; Solla P; Bini V; Puligheddu M; Marrosu F
J Clin Psychopharmacol; 2012 Jun; 32(3):424-5. PubMed ID: 22534502
[No Abstract] [Full Text] [Related]
4. Optimizing levodopa therapy to treat wearing-off symptoms in Parkinson's disease: focus on levodopa/carbidopa/entacapone.
Reichmann H; Emre M
Expert Rev Neurother; 2012 Feb; 12(2):119-31. PubMed ID: 22288667
[TBL] [Abstract][Full Text] [Related]
5. Parkinson disease: adjunctive entacapone therapy increases risk of dyskinesia.
Sampaio C; Ferreira JJ
Nat Rev Neurol; 2010 Nov; 6(11):590-1. PubMed ID: 21048799
[No Abstract] [Full Text] [Related]
6. Quality of life in early Parkinson's disease treated with levodopa/carbidopa/entacapone.
Fung VS; Herawati L; Wan Y; ;
Mov Disord; 2009 Jan; 24(1):25-31. PubMed ID: 18846551
[TBL] [Abstract][Full Text] [Related]
7. Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease.
Hauser RA; Panisset M; Abbruzzese G; Mancione L; Dronamraju N; Kakarieka A;
Mov Disord; 2009 Mar; 24(4):541-50. PubMed ID: 19058133
[TBL] [Abstract][Full Text] [Related]
8. Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study.
Stocchi F; Rascol O; Kieburtz K; Poewe W; Jankovic J; Tolosa E; Barone P; Lang AE; Olanow CW
Ann Neurol; 2010 Jul; 68(1):18-27. PubMed ID: 20582993
[TBL] [Abstract][Full Text] [Related]
9. [Stalevo (levodopa/carbidopa/entacapon)--a new generation drug in the treatment of Parkinson's disease].
Fedorova NV; Levin OS; Smolentseva IG; Kulua TK
Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(9):39-46. PubMed ID: 17069061
[TBL] [Abstract][Full Text] [Related]
10. Effect of levodopa and entacapone treatment on plasma homocysteine levels in Parkinson's disease patients.
Nevrly M; Kanovsky P; Vranova H; Langova K; Hlustik P
Parkinsonism Relat Disord; 2009 Jul; 15(6):477-8. PubMed ID: 19028438
[No Abstract] [Full Text] [Related]
11. Treatment of end-of-dose wearing-off in parkinson's disease: stalevo (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess/Comtan (entacapone) provide equivalent improvements in symptom control superior to that of traditional levodopa/DDCI treatment.
Brooks DJ; Agid Y; Eggert K; Widner H; Ostergaard K; Holopainen A;
Eur Neurol; 2005; 53(4):197-202. PubMed ID: 15970632
[TBL] [Abstract][Full Text] [Related]
12. Stalevo for Parkinson's disease.
Med Lett Drugs Ther; 2004 May; 46(1182):39-40. PubMed ID: 15136772
[No Abstract] [Full Text] [Related]
13. Foot dystonia heralding levodopa-induced dyskinesias in Parkinson disease.
Pouclet H; Derkinderen P; Lebouvier T
Clin Neurol Neurosurg; 2013 Feb; 115(2):235-6. PubMed ID: 22743235
[No Abstract] [Full Text] [Related]
14. Levodopa/carbidopa/entacapone in Parkinson's disease.
Seeberger LC; Hauser RA
Expert Rev Neurother; 2009 Jul; 9(7):929-40. PubMed ID: 19589043
[TBL] [Abstract][Full Text] [Related]
15. Clinical inquiry. Which drugs work best for early Parkinson's disease?
Jain L; Benko R; Safranek S
J Fam Pract; 2012 Feb; 61(2):106-8. PubMed ID: 22312616
[TBL] [Abstract][Full Text] [Related]
16. Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy.
Manca D; Cossu G; Murgia D; Molari A; Ferrigno P; Marcia E; Melis M
Mov Disord; 2009 Nov; 24(15):2293-4. PubMed ID: 19795477
[No Abstract] [Full Text] [Related]
17. [Advanced course of Parkinson disease. Little improved motion with continuous intestinal levodopa administration].
Oberpichler-Schwenk H
Med Monatsschr Pharm; 2005 Jul; 28(7):245-6. PubMed ID: 16038123
[No Abstract] [Full Text] [Related]
18. Levodopa-carbidopa intestinal gel for treatment of advanced Parkinson's disease.
Fernandez HH; Odin P
Curr Med Res Opin; 2011 May; 27(5):907-19. PubMed ID: 21351823
[TBL] [Abstract][Full Text] [Related]
19. Parcopa: a rapidly dissolving formulation of carbidopa/levodopa.
Med Lett Drugs Ther; 2005 Jan; 47(1201):12. PubMed ID: 15706700
[TBL] [Abstract][Full Text] [Related]
20. Clinical profile of levodopa-carbidopa-entacapone intestinal gel infusion in patients with advanced Parkinson's disease.
Atanasova-Ivanova KA; Hristova-Chakmakova SI; Milanov IG
Folia Med (Plovdiv); 2023 Dec; 65(6):929-932. PubMed ID: 38351782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
